Last reviewed 2026-04-20 · How we verify

Zocor

Hanmi Pharmaceutical Company Limited · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Zocor
Sponsor	Hanmi Pharmaceutical Company Limited
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial (PHASE1)
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis (PHASE2)
Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer (PHASE1, PHASE2)
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer (PHASE2)
Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis (PHASE4)
Triple Antibiotic Paste vs Simvastatin for Lesion Sterilization and Tissue Repair in Primary Molars. (PHASE2)
KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism (NA)
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results